Trial intelligence / Profile preview

Ledipasvir + sofosbuvir for chronic hepatitis C genotype 1

IRCT2016050717413N15Phase 2Completed

Sponsor
Baqiyatallah Research Center for Gastroenterology and Liver Diseases
Start
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of ledipasvir and sofosbuvir in hepatitis C virus infection, sponsored by Baqiyatallah Research Center for Gastroenterology and Liver Diseases. Started Mar 2015; status: completed.

02

Drugs

ledipasvirsofosbuvir
03

Conditions

hepatitis C virus infection

Beyond the preview

Go deeper on IRCT2016050717413N15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016050717413N15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call